📰 Aptose Bioscience News
Page 2 - Aptose Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aptose Bioscience. Real-time updates on events, politics, business and more.
August 5, 2022
Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Investment analysts at Oppenheimer upped their FY2025 EPS estimates for Aptose Biosciences in a note issued to investors on Tuesday, August 2nd. Oppenheimer analyst M. Biegler now expects that the biotechnology company will earn $0.33 per share for the year, up from their prior forecast of […]
August 5, 2022
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
June 1, 2022
Aptose Biosciences (NASDAQ:APTO – Get Rating) and Caribou Biosciences (NASDAQ:CRBU – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings. Institutional and Insider Ownership 34.2% of Aptose Biosciences shares […]
March 26, 2022
Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Investment analysts at Piper Sandler issued their Q1 2023 earnings estimates for shares of Aptose Biosciences in a report released on Tuesday, March 22nd. Piper Sandler analyst E. Tenthoff anticipates that the biotechnology company will earn ($0.16) per share for the quarter. Piper Sandler also issued […]
March 25, 2022
Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Stock analysts at Oppenheimer issued their Q1 2022 earnings estimates for shares of Aptose Biosciences in a research note issued to investors on Wednesday, March 23rd. Oppenheimer analyst M. Biegler expects that the biotechnology company will post earnings per share of ($0.13) for the quarter. Oppenheimer […]